Needham Maintains Buy on Globus Medical, Raises Price Target to $117
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $114 to $117.
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $114 to $117.